WAKAMOTO PHARMACEUTICAL CO., LTD.
|WAKAMOTO PHARMACEUTICAL CO., LTD. Patent applications|
|Patent application number||Title||Published|
|20130149394||AQUEOUS OPHTHALMIC COMPOSITION - The invention provides an aqueous ophthalmic composition, containing a beta blocker such as timolol, carteolol or the like, and a sugar alcohol such as mannitol, sorbitol or the like, optionally together with boric acid. The composition of the invention can improve the corneal permeability of a drug, so that the dose of the drug can be lowered, for example by decreasing the frequency of application to the eyes. It is therefore expected that the risk of systemic side effects which may be induced by the application of the beta blocker to the eyes, including cardiotoxicity or respiratory toxicity can be reduced. The decrease in the frequency of application of ophthalmic solution can favorably improve the QOL and prevent the decrease of therapeutic effect which may be caused by missing the application to the eyes.||06-13-2013|
|20120070536||LACTOBACILLUS STRAIN AND FOOD HAVING ANTIFUNGAL ACTIVITY - An object of the present invention is to provide a novel strain that is capable of effectively inhibiting the growth of microorganisms such as fungi and||03-22-2012|
|20110263587||REVERSIBLY HEAT-GELABLE AQUEOUS COMPOSITION - The present invention relates to a reversibly heat-gelable aqueous composition comprising a reversibly heat-gelable aqueous composition according to conventional technique, to which a thixotropic property-increasing substance is added. The thixotropic property-increasing substance is preferably at least one member selected from the group consisting of sugar alcohol, lactose, carmellose or pharmaceutically acceptable salts thereof and cyclodextrin. This composition can be stored at room temperature and accordingly, it is quite convenient for users to carry about the same.||10-27-2011|
|20090169492||Oral Cavity Composition - The object of the present invention is to provide an oral cavity composition which is nontoxic, excellent in plaque control, can prevent or treat onset of caries and periodontal disease caused by oral pathogens as well as can prevent or eliminate bad breath. The invention provides an oral cavity composition containing a lactic acid bacterium,||07-02-2009|
Patent applications by WAKAMOTO PHARMACEUTICAL CO., LTD.